Teleflex to Support Responding to Cardiac Arrest at ERC Congress 2019, in Ljubljana, Slovenia from September 19th – 21st
September 13 2019 - 6:45AM
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies, will focus on its Arrow® EZ-IO® Intraosseous
Access System and on the campaigns “What could 10 seconds to
vascular access mean to your cardiac arrest patient?” and “Act
Fast” at the ERC Congress being held in Ljubljana, Slovenia on
September 19-21, 2019.
Cardiac Arrest remains one of the leading causes of mortality in
the world.1,2
Prompt treatment is essential for all cardiac arrest patients,
whether a patient suffers an in-hospital cardiac arrest (IHCA) or
an out-of-hospital cardiac arrest (OHCA). US and European based
studies have found an incidence rate of 84 OHCAs per 100,000
population2 and between 1.51-2.85 IHCA per 1.000 hospital patient
admissions.3,4 The incidence of cardiac arrest is a serious health
problem within Europe and the United States.
When a cardiac arrest occurs, rapid delivery of fluids and
medication is key to treatment. Clinicians need fast methods
of establishing vascular access, and IV access may be difficult or
impossible due to cardiovascular collapse and environmental
challenges.
The Arrow® EZ-IO® Intraosseous Vascular Access System from
Teleflex is a fast, safe and effective solution in emergency
situations 5,6,7,8. The EZ-IO® System is indicated anytime vascular
access is difficult to obtain in emergent, urgent, or medically
necessary cases for up to 72 hours within Europe. The EZ-IO System
is a difficult vascular access option that provides peripheral
venous access with central venous catheter performance when
inserted into the adult proximal humerus.7,8,9,10,11,12
While ERC is taking place, the Teleflex Clinical & Medical
Affairs team will run several in-booth educational sessions to
enhance healthcare providers’ understanding of emergency procedures
through the use of Teleflex products, including the Arrow® EZ-IO®
Intraosseous Vascular Access System and products for pelvic
stabilization, nasal atomization, airway management and
endotracheal intubation.
Moreover, in conjunction with the European Resuscitation Council
Congress, the Teleflex Clinical & Medical Affairs team will be
running two workshops during the conference. Prior booking is
required. Healthcare professions attending ERC who are
interested in attending the workshops can register via the
following links:
- Trauma Cadaveric Procedural Laboratory workshop
http://TeleflexCMA.formstack.com/forms/erc2019lab
- ‘Right Line, Right Now!’ vascular access procedural workshop
https://teleflexcma.formstack.com/forms/erc_rlrn
About Teleflex Incorporated Teleflex is a
global provider of medical technologies designed to improve the
health and quality of people’s lives. We apply purpose driven
innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio
is diverse, with solutions in the fields of vascular access,
interventional cardiology and radiology, anesthesia, emergency
medicine, surgical, urology and respiratory care. Teleflex
employees worldwide are united in the understanding that what we do
every day makes a difference. For more information, please visit
teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a
common sense of purpose.
Forward-Looking Statements Any statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which
may cause actual results or company actions to differ materially
from what is expressed or implied by these statements. These risks
and uncertainties are identified and described in more detail in
our filings with the Securities and Exchange Commission, including
our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO,
Hudson RCI, LMA, Pilling, Rusch, UroLift and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries. countries ©
2019 Teleflex Incorporated. All rights reserved.
MCI-2019-0485
- Mozaffarian D, Benjamin EJ, Go AS, et al: on behalf of the
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Heart disease and stroke statistics—2015
update: a report from the American Heart Association. Circulation.
2015;131:e29–e322. DOI: 10.1161/CIR.0000000000000152.
- EuReCa ONE 27 Nations, ONE Europe, ONE Registry: A prospective
one month analysis of out-of-hospital cardiac arrest outcomes in 27
countries in Europe, Volume 105, August 2016, Pages 188-195
- Incidence and outcome of in-hospital cardiac arrest in Italy: a
multicentre observational study in the Piedmont Region,
Resuscitation [24 Jun 2017, 119:48-55]
- Public Report Cards for In-Hospital Cardiac Arrest: Empowering
the Public With Location-Specific Data, Circulation. Author
manuscript; available in PMC 2016 Apr 21
- Davidoff J, Fowler R, Gordon D, Klein G, Kovar J, Lozano M,
Potkya J, Racht E, Saussy J, Swanson E, Yamada R, Miller L.
Clinical evaluation of a novel intraosseous device for adults:
prospective, 250-patient, multi-center trial. JEMS
2005;30(10):s20-3. Research sponsored by Teleflex
Incorporated.
- Montez D, Puga T, Miller LJ, et al. Intraosseous
Infusions from the Proximal Humerus Reach the Heart in Less Than 3
Seconds in Human Volunteers. Annals of Emergency Medicine
2015;66(4S):S47. Research sponsored by Teleflex Incorporated.
- Cooper BR, Mahoney PF, Hodgetts TJ, Mellor A. Intra-osseous
access (EZ-IO®) for resuscitation: UK military combat
experience. J R Army Med Corps. 2007;153(4):314-31
- Teleflex Internal Data on file 2018
- Hoskins SL, Nascimento P Jr., Lima RM, Espana-Tenorio, JM,
Kramer GC. Pharmacokinetics of intraosseous and central venous drug
delivery during cardiopulmonary resuscitation. Resuscitation 2011;
doi:10.1016/j.resuscitation.2011.07.041. Research sponsored by
Teleflex Incorporated. (preclinical study)
- Hoskins SL, Zachariah BS, Copper N, Kramer GC. Comparison of
intraosseous proximal humerus and sternal routes for drug delivery
during CPR. Circulation 2007; 116:II_993. Research sponsored by
Teleflex Incorporated. (preclinical study)
- *Compared to single lumen Central Venous Catheters (CVCs).
- **Based on Adult Proximal Humerus EZ-IO® insertion data.
Source: Teleflex Incorporated Jake Elguicze
Treasurer and Vice President, Investor Relations 610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Sep 2023 to Sep 2024